GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,486.80p
   
  • Change Today:
    -0.80p
  • 52 Week High: 1,619.40
  • 52 Week Low: 1,242.80
  • Currency: UK Pounds
  • Shares Issued: 4,960.32m
  • Volume: 6,426,495
  • Market Cap: 73,750m
  • RiskGrade: 80
  • Beta: 0.01

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.4% 5.4%
Div Cover 1.4 1.4
Op Mrgn 13.5% 25.4%
ROCE n/a  
Latest F'cast
P/E 13.3 13.4
PEG 1.4 n/a
Pr/Revenue 2.4 2.4
Pr/Book 21.1  
Latest F'cast
Revenue 8.2% 0.6%
PBT 81.8% 118.7%
EPS 9.2% -0.7%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 30,365.43 7,708.09 111.06p 13.4 n/a -1% 80.01p 5.4%
31-Dec-19 31,175.97 7,764.45 115.23p 12.9 3.4 +4% 80.23p 5.4%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
11-Sep-18 Transfer From Emma Walmsley 0.000p 8 0.00
11-Sep-18 Transfer From Simon Dingemans 0.000p 8 0.00
11-Sep-18 Transfer From David Redfern 0.000p 8 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,486.80p
Change Today -0.80p
% Change -0.05 %
52 Week High 1,619.40
52 Week Low 1,242.80
Volume 6,426,495
Shares Issued 4,960.32m
Market Cap 73,750m
Beta 0.01
RiskGrade 80

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33% below the market average33% below the market average33% below the market average33% below the market average33% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
25.16% above the market average25.16% above the market average25.16% above the market average25.16% above the market average25.16% above the market average
32.31% above the sector average32.31% above the sector average32.31% above the sector average32.31% above the sector average32.31% above the sector average
Income
74.19% above the market average74.19% above the market average74.19% above the market average74.19% above the market average74.19% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
31.95% above the market average31.95% above the market average31.95% above the market average31.95% above the market average31.95% above the market average
19.05% below the sector average19.05% below the sector average19.05% below the sector average19.05% below the sector average19.05% below the sector average

What The Brokers Say

Strong Buy 10
Buy 2
Neutral 11
Sell 0
Strong Sell 2
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 09-Aug-18 10-May-18
Paid 11-Oct-18 12-Jul-18
Amount 19.00p 19.00p

Trades for 18-Sep-2018

Time Volume / Share Price
16:51 300 @ 1,480.80p
16:51 9,200 @ 1,483.56p
16:51 2,918 @ 1,481.40p
16:51 5,668 @ 1,480.80p
16:41 130 @ 1,485.48p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page